Page last updated: 2024-10-18

dalteparin and Pemphigoid

dalteparin has been researched along with Pemphigoid in 3 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dyson, SW1
Lin, C1
Jaworsky, C1
Gutjahr, A1
Heck, F1
Emtenani, S1
Hammers, AK1
Hundt, JE1
Muck, P1
Siegel, DL1
Schmidt, E1
Stanley, JR1
Zillikens, D1
Hammers, CM1
Hashimoto, T1
Kanazawa, N1
Inoue, N1

Other Studies

3 other studies available for dalteparin and Pemphigoid

ArticleYear
Enoxaparin sodium-induced bullous pemphigoid-like eruption: a report of 2 cases.
    Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:1

    Topics: Adult; Anticoagulants; Drug Eruptions; Enoxaparin; Female; Fluorescent Antibody Technique; Humans; M

2004
Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.
    The British journal of dermatology, 2019, Volume: 181, Issue:3

    Topics: Autoantibodies; Autoantigens; Collagen Type XVII; Complement Activation; Complement C5a; Complement

2019
Anticomplement therapy in bullous pemphigoid.
    The British journal of dermatology, 2019, Volume: 181, Issue:3

    Topics: Complement Inactivator Proteins; Heparin, Low-Molecular-Weight; Humans; Pemphigoid, Bullous; Tinzapa

2019